Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 51-75 of 103 citing articles:

Self-assembled glycyrrhetinic acid derivatives for functional applications: a review
Linjun Zou, Qinglong Li, Yong Hou, et al.
Food & Function (2022) Vol. 13, Iss. 24, pp. 12487-12509
Closed Access | Times Cited: 16
Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors
Mabrouk Horchani, Niels V. Heise, René Csük, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5303-5303
Open Access | Times Cited: 15
An integrated approach of high‐performance liquid chromatography–mass spectrometry‐based chemical profiling, network pharmacology, and molecular docking to reveal the potential mechanisms of Qishen Gubiao granules for treating coronavirus disease 2019
Shu‐Yun Yang, Ming‐Xia Lu, Yun‐Qian Zhang, et al.
Journal of Separation Science (2023) Vol. 46, Iss. 10
Closed Access | Times Cited: 8
Antiviral properties of diterpenes and their derivatives
Оlga I. Yarovaya, Sergey S. Laev, Нариман Ф. Салахутдинов
Russian Chemical Reviews (2023) Vol. 92, Iss. 1, pp. RCR5056-RCR5056
Closed Access | Times Cited: 8
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations
Fatma G. Abdulrahman, Hamada S. Abulkhair, Riham A. Zidan, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 105-123
Closed Access | Times Cited: 2
Design, Synthesis of Novel Pyrido[2,3-d] pyrimidine Derivatives as SARS-CoV-2 Mpro Inhibitors for COVID-19 Therapy
Eman Mansour, Ahmed M. Sayed, Safaa I. Elewa
Polycyclic aromatic compounds (2024) Vol. 44, Iss. 10, pp. 7061-7086
Closed Access | Times Cited: 2
Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights
Dalia S. El‐Gamil, Mohamed Y. Zaky, Patrick M. Maximous, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access | Times Cited: 2
Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses
В. В. Фоменко, Надежда Б. Рудометова, Оlga I. Yarovaya, et al.
Molecules (2022) Vol. 27, Iss. 1, pp. 295-295
Open Access | Times Cited: 14
Potential topoisomerases inhibitors from Aspergillus terreus using virtual screening
Eman Zekry Attia, Basma Ali Khalifa, Gehan M. Shaban, et al.
South African Journal of Botany (2022) Vol. 149, pp. 632-645
Open Access | Times Cited: 14
Glimepiride ameliorates renal toxicity induced by cadmium in mice: Modulation of Jun N terminal kinase (JNK)/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinases (PI3K)/protein kinase (AKT) pathways
Mohamed Kh. ElMahdy, Mennatallah O. Zaki, Ahmed A. Al‐Karmalawy, et al.
Life Sciences (2022) Vol. 311, pp. 121184-121184
Closed Access | Times Cited: 14
Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants
Waseem Ahmad Ansari, Mohd Aamish Khan, Fahmina Rizvi, et al.
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 558-578
Open Access | Times Cited: 13
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zhonglei Wang, Xian-qing Song, Wenjing Xu, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3885-3885
Open Access | Times Cited: 7
Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
Howaida I. Abd‐Alla, Omnia Kutkat, Heba-tollah M. Sweelam, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1109-1109
Open Access | Times Cited: 12
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
Varun Aggarwal, Ekta Bala, Pawan Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1664-1698
Closed Access | Times Cited: 6
Experimental design of D-α-tocopherol polyethylene glycol 1000 succinate stabilized bile salt based Nano-vesicles for improved cytotoxicity and bioavailability of colchicine binding site inhibitor Candidates: In Vitro, in silico, and pharmacokinetic studies
Ayman Abo Elmaaty, Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 122980-122980
Closed Access | Times Cited: 6
Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS‐CoV‐2‐induced CNS complications
Mehdi Valipour
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3724-3743
Closed Access | Times Cited: 6
Anticoronavirus Evaluation of Antimicrobial Diterpenoids: Application of New Ferruginol Analogues
Mihayl Varbanov, Stéphanie Philippot, Miguel A. González-Cardenete
Viruses (2023) Vol. 15, Iss. 6, pp. 1342-1342
Open Access | Times Cited: 6
Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Sefat Alwarsh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1247-1247
Open Access | Times Cited: 6
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses
Mohamed Ali Hussein, Hosni A. M. Hussein, Ali A. Thabet, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1408-1408
Open Access | Times Cited: 11
Recent Advances in the Pharmacological Activities of Glycyrrhizin, Glycyrrhetinic Acid, and Their Analogs
Ankit Mittal, Mudita Nagpal, Vinod Kumar Vashistha
Revista Brasileira de Farmacognosia (2023) Vol. 33, Iss. 6, pp. 1154-1169
Closed Access | Times Cited: 5
Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
Kalliopi Moschovou, Μαρία Αντωνίου, Eleni Chontzopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15894-15894
Open Access | Times Cited: 5
The role and mechanism of TCM in the prevention and treatment of infectious diseases
Qifei Zou, Yitong Chen, Huanxin Qin, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin
Valeria Manca, Annalisa Chianese, Vanessa Palmas, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 665-665
Open Access | Times Cited: 1
Exploring the potential mechanisms of Danshen against COVID-19 via network pharmacology analysis and molecular docking
Qiang Zhang, Zongsuo Liang, Xiaoqing Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Scroll to top